Furthermore, the 343 TCGA samples were classified according to a novel immune landscape of cancer, which identified tumor as six immune subtypes: Wound Healing (C1), IFN-γ Dominant (C2), Inflammatory (C3), Lymphocyte Depleted (C4), Immunologically Quiet (C5), and TGF-β Dominant (C6) [7]. This evidence concerns the gene IFNG and cancer.